The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“C3aR is a G-protein coupled receptor showing prominent expression in tissue-resident macrophages[39,40] and is the target of two endogenous ligands, the C3-derived anaphylatoxin C3a, and the neural VGF-derived (non-acronymic) peptide TLQP-21[40–45].”
From Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity (2026) · cites this paper as [44]
In the citing paper
“Conditional deletion, or pharmacological inhibition of C3aR by DArg10_Aib20[44], blocked the accumulation of lipid droplets, demonstrating that this receptor plays an essential role in the link between dietary lipids and the LAM signature.”
From Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity (2026) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and dynamics of GPCR signaling complexes
Hilger, D., Masureel, M., & Kobilka, B. K. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-017-0011-7 · Cited by 969 · cited 2×
“Thus, the reported agonist effects of this compound in some cell lines may be attributed to activation of β -arrestin-mediated signaling pathways (4, 24, 69).”
BackgroundThe role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730 · cited 1×
“Knowledge on the role of C3a on metabolism is limited, unlike its established role in immunity (15, 35, 78, 79).”
BackgroundLitvinchuk, A., Wan, Y.-W., Swartzlander, D. B., Chen, F., Cole, A., Propson, N. E., Wang, Q., Zhang, B., Liu, Z., & Zheng, H. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.031 · Cited by 523
Anti-obesity therapy: from rainbow pills to polyagonists
Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199
El Gaamouch, F., Audrain, M., Lin, W.-J., Beckmann, N., Jiang, C., Hariharan, S., Heeger, P. S., Schadt, E. E., Gandy, S., Ehrlich, M. E., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0357-x · Cited by 92
The Role of Complement C3a Receptor in Stroke
Ahmad, S., Bhatia, K., Kindelin, A., & Ducruet, A. F. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08545-7 · Cited by 21
Clearance kinetics of the VGF-derived neuropeptide TLQP-21
Guo, Z., Sahu, B. S., He, R., Finan, B., Cero, C., Verardi, R., Razzoli, M., Veglia, G., Di Marchi, R. D., Miles, J. M., et al. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.06.003 · Cited by 21
Self-citation
Research works printed but not linked: 81
- Ceddia, 2020, A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure, Clin. Sci., 134, 473, 10.1042/CS20190579 · DOI
- Weinstein, 2014, Role of Gsα in central regulation of energy and glucose metabolism, Horm. Metab. Res., 46, 841, 10.1055/s-0034-1387798 · DOI
- Smith, 2018, Biased signalling: from simple switches to allosteric microprocessors, Nat. Rev. Drug Discov., 17, 243, 10.1038/nrd.2017.229 · DOI · Paper page
- Preininger, 2004, G protein signaling: insights from new structures, Sci. STKE, 2004, re3, 10.1126/stke.2182004re3 · DOI
- Kobilka, 2007, G protein coupled receptor structure and activation, Biochim. Biophys. Acta Biomembr., 1768, 794, 10.1016/j.bbamem.2006.10.021 · DOI · Paper page
- Gurevich, 2020, Biased GPCR signaling: possible mechanisms and inherent limitations, Pharmacol. Ther., 211, 107540, 10.1016/j.pharmthera.2020.107540 · DOI
- Violin, 2014, Biased ligands at G-protein-coupled receptors: promise and progress, Trends Pharmacol. Sci., 35, 308, 10.1016/j.tips.2014.04.007 · DOI · Paper page
- Wisler, 2018, Biased G protein–coupled receptor signaling, Circulation, 137, 2315, 10.1161/CIRCULATIONAHA.117.028194 · DOI
- Manglik, 2016, Structure-based discovery of opioid analgesics with reduced side effects, Nature, 537, 185, 10.1038/nature19112 · DOI · Paper page
- Luttrell, 2018, Translating in vitro ligand bias into in vivo efficacy, Cell Signal., 41, 46, 10.1016/j.cellsig.2017.05.002 · DOI
- Markham, 2020, Oliceridine: first approval, Drugs, 80, 1739, 10.1007/s40265-020-01414-9 · DOI
- Tan, 2018, Biased ligands of G protein-coupled receptors (GPCRs): structure-functional selectivity relationships (SFSRs) and therapeutic potential, J. Med. Chem., 61, 9841, 10.1021/acs.jmedchem.8b00435 · DOI
- Klos, 2013, International union of basic and clinical pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors, Pharmacol. Rev., 65, 500, 10.1124/pr.111.005223 · DOI · Paper page
- Quell, 2017, Monitoring C3aR expression using a floxed tdTomato-C3aR reporter knock-in mouse, J. Immunol., 199, 688, 10.4049/jimmunol.1700318 · DOI · Paper page
- Sahu, 2021, The molecular identity of the TLQP-21 peptide receptor, Cell Mol. Life Sci., 78, 7133, 10.1007/s00018-021-03944-1 · DOI · Paper page
- Yanamadala, 2010, Complement in neuroprotection and neurodegeneration, Trends Mol. Med., 16, 69, 10.1016/j.molmed.2009.12.001 · DOI
- Norgauer, 1993, Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein, Eur. J. Biochem., 217, 289, 10.1111/j.1432-1033.1993.tb18245.x · DOI
- Molteni, 2017, Pharmacological and biochemical characterization of TLQP-21 activation of a binding site on CHO cells, Front. Pharmacol., 8, 167, 10.3389/fphar.2017.00167 · DOI
- Stephens, 2012, A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function, Cell Metab., 16, 33, 10.1016/j.cmet.2012.05.011 · doi:10.1016/j.cmet.2012.05.011
- Schraufstatter, 2002, Complement c3a and c5a induce different signal transduction cascades in endothelial cells, J. Immunol., 169, 2102, 10.4049/jimmunol.169.4.2102 · DOI · Paper page
- Gupta, 2012, Phosphorylation of C3a receptor at multiple sites mediates desensitization, β-arrestin-2 recruitment and inhibition of NF-κB activity in mast cells, PLoS One, 7, e46369, 10.1371/journal.pone.0046369 · doi:10.1371/journal.pone.0046369
- Vibhuti, 2011, Distinct and shared roles of β-arrestin-1 and β-arrestin-2 on the regulation of C3a receptor signaling in human mast cells, PLoS One, 6, e19585, 10.1371/journal.pone.0019585 · doi:10.1371/journal.pone.0019585
- Guo, 2011, Regulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinases, PLoS One, 6, 10.1371/journal.pone.0022559 · DOI
- Hsu, 2020, C3a elicits unique migratory responses in immature low-density neutrophils, Oncogene, 39, 2612, 10.1038/s41388-020-1169-8 · doi:10.1038/s41388-020-1169-8
- Hu, 2019, Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways, Eur. J. Pharmacol., 850, 135, 10.1016/j.ejphar.2019.02.020 · DOI
- Fairbanks, 2014, The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity, Pain, 155, 1229, 10.1016/j.pain.2014.03.012 · DOI
- Cero, 2017, The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis, Mol. Metab., 6, 148, 10.1016/j.molmet.2016.10.005 · DOI · Paper page
- Possenti, 2012, Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21, Biochem. J., 441, 511, 10.1042/BJ20111165 · doi:10.1042/bj20111165
- Sahu, 2019, Peptide/receptor Co-evolution explains the lipolytic function of the neuropeptide TLQP-21, Cell Rep., 28, 2567, 10.1016/j.celrep.2019.07.101 · DOI · Paper page
- Alexander, 2021, The concise guide to pharmacology 2021/22: G protein-coupled receptors, Br. J. Pharmacol., 178, S27
- Pasupuleti, 2007, Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans, J. Biol. Chem., 282, 2520, 10.1074/jbc.M607848200 · DOI
- Sonesson, 2007, Antifungal activity of C3a and C3a-derived peptides against Candida, Biochim. Biophys. Acta, 1768, 346, 10.1016/j.bbamem.2006.10.017 · DOI
- Coulthard, 2015, Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth, J. Immunol., 194, 3542, 10.4049/jimmunol.1403068 · DOI · Paper page
- Kanmura, 2010, The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma, J. Gastroenterol., 45, 459, 10.1007/s00535-009-0160-5 · DOI
- Bartolomucci, 2011, The extended granin family: structure, function, and biomedical implications, Endocr. Rev., 32, 755, 10.1210/er.2010-0027 · DOI · Paper page
- Bartolomucci, 2006, TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity, Proc. Natl. Acad. Sci. U. S. A., 103, 14584, 10.1073/pnas.0606102103 · DOI · Paper page
- Jethwa, 2007, VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters, Endocrinology, 148, 4044, 10.1210/en.2007-0038 · doi:10.1210/en.2007-0038
- Fargali, 2014, The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure, FASEB J., 28, 2120, 10.1096/fj.13-239509 · doi:10.1096/fj.13-239509
- Doolen, 2017, Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling, Glia, 65, 1976, 10.1002/glia.23208 · DOI · Paper page
- Li, 2021, The “C3aR antagonist” SB290157 is a partial C5aR2 agonist, Front. Pharmacol., 11, 2241, 10.3389/fphar.2020.591398 · DOI
- Mathieu, 2005, The C3a receptor antagonist SB 290157 has agonist activity, Immunol. Lett., 100, 139, 10.1016/j.imlet.2005.03.003 · DOI
- Olsen, 2020, TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome, Nat. Chem. Biol., 16, 841, 10.1038/s41589-020-0535-8 · DOI · Paper page
- Proctor, 2009, Complement factors C3a and C5a have distinct hemodynamic effects in the rat, Int. Immunopharmacol., 9, 800, 10.1016/j.intimp.2009.03.002 · doi:10.1016/j.intimp.2009.03.002
- Kroeze, 2015, PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome, Nat. Struct. Mol. Biol., 22, 362, 10.1038/nsmb.3014 · DOI · Paper page
- Cero, 2014, The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism, Structure, 22, 1744, 10.1016/j.str.2014.10.001 · doi:10.1016/j.str.2014.10.001
- Kenakin, 2015, The effective application of biased signaling to new drug discovery, Mol. Pharmacol., 88, 1055, 10.1124/mol.115.099770 · DOI
- Kenakin, 2012, A simple method for quantifying functional selectivity and agonist bias, ACS Chem. Neurosci., 3, 193, 10.1021/cn200111m · DOI · Paper page
- Rivolta, 2017, JMV5656, A novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells, Front. Cell. Neurosci., 11, 41, 10.3389/fncel.2017.00041 · DOI
- Beautrait, 2017, A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling, Nat. Commun., 8, 15054, 10.1038/ncomms15054 · DOI · Paper page
- Paksoy, 2022, Effects of the clathrin inhibitor Pitstop-2 on synaptic vesicle recycling at a central synapse in vivo, Front. Synaptic Neurosci., 14, 1056308, 10.3389/fnsyn.2022.1056308 · DOI
- Rowley, 2020, Potent thiophene antagonists of human complement C3a receptor with anti-inflammatory activity, J. Med. Chem., 63, 529, 10.1021/acs.jmedchem.9b00927 · DOI
- Cho, 2020, TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β, Biochem. Biophys. Res. Commun., 524, 764, 10.1016/j.bbrc.2020.01.111 · DOI
- Blasi, 1990, Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus, J. Neuroimmunol., 27, 229, 10.1016/0165-5728(90)90073-V · DOI · Paper page
- Kirshenbaum, 2019, Description and characterization of a novel human mast cell line for scientific study, Int. J. Mol. Sci., 20, 5520, 10.3390/ijms20225520 · DOI
- Ames, 2001, Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models, J. Immunol., 166, 6341, 10.4049/jimmunol.166.10.6341 · DOI · Paper page
- Gorman, 2021, Development of potent and selective agonists for complement C5a receptor 1 with in vivo activity, J. Med. Chem., 64, 16598, 10.1021/acs.jmedchem.1c01174 · DOI
- Pandey, 2019, Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1, J. Biol. Chem., 294, 9416, 10.1074/jbc.RA119.007485 · DOI
- Yang, 2017, Biased signaling at neural melanocortin receptors in regulation of energy homeostasis, Biochim. Biophys. Acta Mol. Basis Dis., 1863, 2486, 10.1016/j.bbadis.2017.04.010 · DOI
- Ghamari-Langroudi, 2015, G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons, Nature, 520, 94, 10.1038/nature14051 · DOI · Paper page
- Lotta, 2019, Human gain-of-function MC4R variants show signaling bias and protect against obesity, Cell, 177, 597, 10.1016/j.cell.2019.03.044 · DOI · Paper page
- Li, 2023, TLQP-21 is a low potency partial C3aR activator on human primary macrophages, Front. Immunol., 14
- Hutamekalin, 2010, Effect of the C3a-receptor antagonist SB 290157 on anti-OVA polyclonal antibody-induced arthritis, J. Pharmacol. Sci., 112, 56, 10.1254/jphs.09180FP · DOI
- Grundmann, 2018, Lack of beta-arrestin signaling in the absence of active G proteins, Nat. Commun., 9, 341, 10.1038/s41467-017-02661-3 · DOI · Paper page
- Li, 2008, Cyclic AMP plays a critical role in C3a-receptor mediated regulation of dendritic cells in antigen uptake and T-cell stimulation, Blood, 112, 5084, 10.1182/blood-2008-05-156646 · DOI
- Reid, 2013, Downsizing a human inflammatory protein to a small molecule with equal potency and functionality, Nat. Commun., 4, 2802, 10.1038/ncomms3802 · doi:10.1038/ncomms3802
- Rizzi, 2008, The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain, Neurosci. Lett., 441, 129, 10.1016/j.neulet.2008.06.018 · DOI
- Sarma, 2011, The complement system, Cell Tissue Res., 343, 227, 10.1007/s00441-010-1034-0 · DOI · Paper page
- Koc, 2021, Changes in VGF and C3aR1 gene expression in human adipose tissue in obesity, Mol. Biol. Rep., 48, 251, 10.1007/s11033-020-06043-9 · DOI · Paper page
- Lisci, 2019, Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21, PLoS One, 14, e0221517, 10.1371/journal.pone.0221517 · DOI
- Mamane, 2009, The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation, Diabetes, 58, 2006, 10.2337/db09-0323 · DOI · Paper page
- Lewis, 2017, Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gain, PLoS One, 12
- Regal, 2000, Minor role of the C3a receptor in systemic anaphylaxis in the Guinea pig, Immunopharmacology, 46, 15, 10.1016/S0162-3109(99)00152-6 · doi:10.1016/s0162-3109(99)00152-6
- Song, 2016, Small molecule-induced complement factor D (adipsin) promotes lipid accumulation and adipocyte differentiation, PLoS One, 11
- Lim, 2013, C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling, FASEB J., 27, 822, 10.1096/fj.12-220582 · DOI · Paper page
- Kashem, 2011, G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2, Eur. J. Pharmacol., 668, 299, 10.1016/j.ejphar.2011.06.027 · DOI
- Wang, 2023, Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins, Nat. Chem. Biol., 19, 1351, 10.1038/s41589-023-01339-w · DOI
- Yadav, 2023, Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors, Cell, 186, 4956, 10.1016/j.cell.2023.09.020 · DOI
- Settmacher, 2003, Structure-function studies of the C3a-receptor: C-terminal serine and threonine residues which influence receptor internalization and signaling, Eur. J. Immunol., 33, 920, 10.1002/eji.200323293 · DOI
- Lewis, 2023, A non-hallucinogenic LSD analog with therapeutic potential for mood disorders, Cell Rep., 42, 10.1016/j.celrep.2023.112203 · DOI
- Chan, 2014, Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype, J. Allergy Clin. Immunol., 134, 178, 10.1016/j.jaci.2013.12.1090 · DOI
- Woolhiser, 2001, IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma, Eur. J. Immunol., 31, 3298, 10.1002/1521-4141(200111)31:11<3298::AID-IMMU3298>3.0.CO;2-U · DOI
Cited by
Pallais, J. P., Razzoli, M., Rodriguez, P., McGonigle, S., Daugherty, A., Hillman, H., Verteramo, L., Schrank, P. R., Parthiban, P., Chang, X., et al. (2026) · doi:10.64898/2026.04.18.719397 · Cited by 1
Self-citation
Metadata
- Authors
- Rodriguez, P., Laskowski, L. J., Pallais, J. P., Bock, H. A., Cavalco, N. G., Anderson, E. I., Calkins, M. M., Razzoli, M., Sham, Y. Y., McCorvy, J. D., & Bartolomucci, A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2024-01
- Volume
- 300
- Issue
- 1
- Pages
- 105549
- ISSN
- 0021-9258
- Cited by
- 30
- References
- 7
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK102496, R01DK117504)
- National Institutes of Health
- National Institute of General Medical Sciences (R35GM133421, T32DK083250)
- National Institute of Allergy and Infectious Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism. https://app.cochat.ai/papers/10.1016/j.jbc.2023.105549
- The paper
- Rodriguez, P., Laskowski, L. J., Pallais, J. P., Bock, H. A., Cavalco, N. G., Anderson, E. I., Calkins, M. M., Razzoli, M., Sham, Y. Y., McCorvy, J. D., & Bartolomucci, A. (2024). Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105549
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.